Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Long peptide vaccine 7 |
| Synonyms | |
| Therapy Description |
Long peptide vaccine 7 is a cancer vaccine that contains synthetic peptides based on cancer-testis antigens and melanocytic differentiation proteins, which may induce an anti-tumor immune response (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Long peptide vaccine 7 | LPV7 | Long peptide vaccine 7 is a cancer vaccine that contains synthetic peptides based on cancer-testis antigens and melanocytic differentiation proteins, which may induce an anti-tumor immune response (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02126579 | Phase Ib/II | Poly ICLC Long peptide vaccine 7 | Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists | Completed | USA | 0 |